Latest News and Press Releases

CLINUVEL has met its recruitment target in its phase III trial (CUV105) of SCENESSE® (afamelanotide 16mg) in vitiligo, with more than 200 patients enrolled

Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Vitiligo Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering.The vitiligo treatment pipeline analysis provides an...

Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Vitiligo Market Report, Forecast by Diseases Type, Treatment Type, End User, Countries and Company Analysis, 2024-2032" report has been added to ...

Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Vitiligo - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Vitiligo - Pipeline Insight, 2024" report...

Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Vitiligo Treatment Global Market Report 2023" has been added to ResearchAndMarkets.com's offering. The global vitiligo treatment market is expected...

Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The "Vitiligo Treatment Market, Size, Share, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report...

Portland, OR, Nov. 10, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global vitiligo treatment market was estimated at $410.5 million in 2021 and is...

Los Angeles, June 03, 2021 (GLOBE NEWSWIRE) -- Vitiligo Pipeline - Current Treatments, Drug Pipeline and Clinical Trial Outlook | Insights by DelveInsight Prominent companies such as Incyte...

SEATTLE, June 02, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global vitiligo drug market is estimated to be valued at US$ 151.9 million in 2020 and is expected to exhibit a...

Pune, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Global vitiligo treatment market is likely to gain impetus from an ever rising demand for innovative and modern treatment options for vitiligo. According to...